Cefoperazone: Difference between revisions
m Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
No edit summary |
||
Line 1: | Line 1: | ||
{{ | __NOTOC__ | ||
{{Cefoperazone}} | |||
{{CMG}};{{AE}}{{AK}} | |||
}} | |||
{{ | |||
==Overview== | ==Overview== | ||
Line 32: | Line 7: | ||
''Cefina-SB'' is a combination of [[sulbactam]] and cefoperazone. Cefoperazone exerts its bactericidal effect by inhibiting the [[bacterial]] [[cell wall]] synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase producing organisms. Cefina-SB is available as injection for the treatment of bacterial infections. In some countries, the combination is sold as ''Sulperazone''. Cefoperazone is available in the United States as Cefobid. | ''Cefina-SB'' is a combination of [[sulbactam]] and cefoperazone. Cefoperazone exerts its bactericidal effect by inhibiting the [[bacterial]] [[cell wall]] synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase producing organisms. Cefina-SB is available as injection for the treatment of bacterial infections. In some countries, the combination is sold as ''Sulperazone''. Cefoperazone is available in the United States as Cefobid. | ||
==Category== | |||
[[Cephalosporins]], third generation. | |||
==US Brand Names== | |||
CEFOBID<sup>®</sup> | |||
==FDA Package Insert== | |||
''' [[cefoperazone description|Description]]''' | |||
'''| [[cefoperazone clinical pharmacology|Clinical Pharmacology]]''' | |||
'''| [[cefoperazone microbiology|Microbiology]]''' | |||
'''| [[cefoperazone indications and usage|Indications and Usage]]''' | |||
'''| [[cefoperazone contraindications|Contraindications]]''' | |||
'''| [[cefoperazone warnings and precautions|Warnings and Precautions]]''' | |||
'''| [[cefoperazone adverse reactions|Adverse Reactions]]''' | |||
'''| [[cefoperazone overdosage|Overdosage]]''' | |||
'''| [[cefoperazone clinical studies|Clinical Studies]]''' | |||
'''| [[cefoperazone dosage and administration|Dosage and Administration]]''' | |||
'''| [[cefoperazone Compatibility and Stability|Compatibility and Stability]]''' | |||
'''| [[cefoperazone how supplied|How Supplied]]''' | |||
'''| [[cefoperazone labels and packages|Labels and Packages]]''' | |||
{{CephalosporinAntiBiotics}} | {{CephalosporinAntiBiotics}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
==References== | |||
{{Reflist|2}} | |||
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c2ef3b-2c53-4737-9f7d-2d7e040c6e87 | |||
[[Category:Antibiotics]] | |||
[[Category:Wikinfect]] |
Revision as of 05:31, 7 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Overview
Cefoperazone is a third generation cephalosporin antibiotic. Marketed by pfizer under the name Cefobid®.
Cefina-SB is a combination of sulbactam and cefoperazone. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase producing organisms. Cefina-SB is available as injection for the treatment of bacterial infections. In some countries, the combination is sold as Sulperazone. Cefoperazone is available in the United States as Cefobid.
Category
Cephalosporins, third generation.
US Brand Names
CEFOBID®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility and Stability | How Supplied | Labels and Packages
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c6c2ef3b-2c53-4737-9f7d-2d7e040c6e87